Navigation Links
Kanzius Cancer Research Foundation Earns $1 for Each New Facebook Fan

ERIE, Pa., April 14, 2011 /PRNewswire/ -- In an effort to match last year's $250,000 Pepsi Refresh Everything grant, the Kanzius Cancer Research Foundation (KCRF) launched the "Repeat the Wave" Campaign on April 1 raising over $40,000 and adding more than 4,000 new Facebook fans in thirteen days. Until April 30, KCRF is increasing awareness and raising additional funds for research of the Kanzius Non-Invasive Radiowave Cancer Treatment by asking the public to "like" them on Facebook.

An anonymous donor has agreed to donate one dollar for each new KCRF Facebook fan as well as match fifty cents for each dollar donated to the Foundation. After a Facebook user likes the page, they are then encouraged to "Spread the Wave" by inviting all of their Facebook friends to also "like" the Kanzius Cancer Research Foundation page. The campaign urges KCRF supporters to use a special landing page,, and invite their social networks to spread the wave just like last April, when Internet users and Facebook fans voted KCRF's project as the most "refreshing idea" during the Pepsi Refresh Everything contest. Since the start of this campaign, KCRF has increased support on local, national and global levels.

"A year ago, we embarked on a journey to 'Spread the Wave' and thanks to overwhelming community support, we won the Pepsi contest resulting in a grant of $250,000 to educate new audiences; this has truly transformed our foundation," said Mark A. Neidig, Sr., executive director of Kanzius Foundation. "Today, I am once again humbled by the tremendous support for the 'Repeat the Wave' campaign.  No doubt, everyone has been touched by cancer in some way.  The 'Kanzius Way' of treating cancer non-invasively and without side effects is why we won the grant last year and today, this timely message is still refreshing and worth repeating!"

About the Kanzius Cancer Research Foundation

The Kanzius Cancer Research Foundation is a 501(c) (3) non-profit organization with a mission to create national and global awareness of the potentials of the Kanzius Non-invasive Radiowave Cancer Treatment, and to help accelerate the speed at which this research progresses to human trials. The goal of KCRF is to raise money to support ongoing research grants.  Pancreatic, liver and colorectal cancers in test subjects are undergoing extensive research in Houston and Pittsburgh; additional, ongoing studies are currently focused on breast, leukemic, lung, melanomic and prostate cancers. John Kanzius' sophisticated radio transmission machine is being manufactured in Erie, Pa.  For more information about the Kanzius research, visit

SOURCE Kanzius Cancer Research Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Novel Technology Breaks Through Cancer Pain
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
(Date:11/26/2015)... 26, 2015 ... aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie voor ... ) --> ... ) Uit ... Centrum (LUMC) blijkt ...
(Date:11/26/2015)... FRANCISCO , November 26, 2015 ... billion by 2022, according to a new report by Grand ... Chronic Kidney Disease (CKD) which demands kidney transplantation is expected ... and cost effective substitute for organ transplantation. --> ... billion by 2022, according to a new report by Grand ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the Global Cell Surface Testing ... Opportunities" report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology:
(Date:11/25/2015)... , ... November 25, 2015 , ... On November 10, ... States District Court of Connecticut on behalf of a home health care worker who ... current or former home health care workers employed by Humana, Inc., Humana at Home, ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... is encouraging people across the country to celebrate their sobriety and show through ... to post “before and after” photos this Thanksgiving with the hashtag #FacesOfGratitude on ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... physicians and athletic programs, launches new Wimbledon Athletics Facebook page to ... young athletes for unsuspected cardiac abnormalities. About 2,000 people under the age of ...
(Date:11/25/2015)... ... 2015 , ... Smiles by Stevens is pleased to announce the ... While many patients are aware of the benefits of Botox® in the treatment of ... suffering with discomfort, soreness, and pain as a result of Jaw Tension, TMJ (temporo-mandibular ...
(Date:11/25/2015)... ... November 25, 2015 , ... Brillianteen, McGaw YMCA’s ... learning in its 65th Anniversary Brillianteen Revue, scheduled for March 4-6, 2016. Auditions ... 65 years, Brillianteen has been a treasured tradition for numerous families in the ...
Breaking Medicine News(10 mins):